Table 2—

Pharmacokinetics based on 6-h serum insulin profiles

AspartLisproANOVA (ratio [90% CI])
Cmax (pmol/l) 271.4 ± 29.3 257.6 ± 20.5 1.01 [0.95–1.11] 
AUC(0–4 h) (pmol · l−1 · min) 23,653.6 ± 2269.9 23,411.1 ± 1896.8 0.99 [0.90–1.08] 
AUC(0–6 h) (pmol · l−1 · min) 24,074.3 ± 2321.8 24,537.2 ± 2119.3 0.97 [0.88–1.06] 
AUC(4–6 h) (pmol · l−1 · min) 420.7 ± 113.4 1,126 ± 385.2 0.62 [0.30–1.27] 
AspartLisproANOVA (ratio [90% CI])
Cmax (pmol/l) 271.4 ± 29.3 257.6 ± 20.5 1.01 [0.95–1.11] 
AUC(0–4 h) (pmol · l−1 · min) 23,653.6 ± 2269.9 23,411.1 ± 1896.8 0.99 [0.90–1.08] 
AUC(0–6 h) (pmol · l−1 · min) 24,074.3 ± 2321.8 24,537.2 ± 2119.3 0.97 [0.88–1.06] 
AUC(4–6 h) (pmol · l−1 · min) 420.7 ± 113.4 1,126 ± 385.2 0.62 [0.30–1.27] 

Data are means ± SE.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept